Top Tech Companies (766)
Don't see your company?
Create a company profile
AIT Bioscience offers bioanalytical contract research services for preclinical and clinical trials.
BRC is a pharmaceutical manufacturing and development firm focused on the production of DEA approved cannabinoid API and botanically derived therapeutics. Our mission is to provide federally compliant, active pharmaceutical ingredients and plant-based therapeutics, with uncompromising quality, for patients and researchers everywhere.
Cylene Pharmaceuticals discovers, develops and commercializes small molecule drugs that target nucleolus and kill cancer cells.
We are a digital-first, life sciences commercialization company. We help biopharmaceutical, emerging biotech and medical device companies develop products, get them to the market, and grow their impact through the life cycle in a more effective, efficient, and modern way. We bring together healthcare domain expertise, fit-for-purpose technology, and an agile operating model to provide a diverse range of solutions. These aim to deliver, amongst other outcomes, a personalized, scalable and omnichannel experience for patients and physicians. It’s what drives our team and our purpose to enable healthcare organizations to be future ready.
WithMe Health is an innovative pharmacy benefits company that works directly with employers and health benefit vendors to provide you and your family with easy to understand pharmacy benefits. WithMe provides personalized medication guidance, with hands-on support from Medication Guides (expert pharmacists and pharmacy technicians) as well as an easy-to-use mobile app to help you manage your medications and see ways to save money. Our mission is to create a significantly better medication experience for all our members, putting their health and needs first as they navigate the complexity of medications by offering our clinical expertise to them and their trusted providers to save them money and to improve their health. We’re unsatisfied with the status quo in pharmacy benefits management and medication guidance. We know that we can provide an easier and more personalized, cost-effective, and equitable experience for members, while helping our clients--those who provide pharmacy benefits--make a more impactful investment in their members’ health. To date, we’ve raised over $40 million from Oak HC/FT, OMERS Ventures, and other leading healthcare VCs and strategic partners to take on the $450+ billion PBM industry.
Longevity Biotech develops a new class of therapeutics via artificial protein technology that focuses on pharmaceutical preparation.
Anaphore is developing protein pharmaceuticals to address significant unmet medical needs for patients with serious diseases. RuiYi is a Wholly Foreign-Owned Enterprise (WFOE) located in the Zhangjiang Hi-Tech Park in Pudong Shanghai, China. RuiYi is developing biologic therapies that target G protein coupled receptors (GPCRs).
Curium is the global leader in nuclear medicine, providing life-changing diagnostics and treatment to patients all over the world. We develop, manufacture and distribute world-class radiopharmaceutical products with a renewed focus on cancer, exploring untapped potential for new innovation. We build on remarkable foundations and a legacy of providing reliable and consistent nuclear solutions to tens of thousands of patients every day. Our proven heritage combined with a pioneering approach are the hallmarks from which we provide life-changing diagnostics and therapeutics. Our people are the root of the incredible impact they have. As part of our 2030 vision to become an oncology-focused nuclear medicine leader – both in diagnostics and therapy – we will expand our reach further into Japan and China, continuing to roll out our superior products to a global market. The impact of these investments on patients will be life changing. Our cancer focus is currently in Neuroendocrine Tumors (NETs) and prostate cancer PSMA. We are also working on leveraging the power of AI to improve image quality and accuracy; to identify patterns to help diagnose pathologies and of course to better support physicians. Our Promise We strive to make the impossible possible and to be an organization that will change the face of medicine. Our diverse group of industry experts is unified under one strong and singular focus – to develop, manufacture and supply revolutionary diagnostic and therapeutic radiopharmaceuticals to our customers around the globe with unrivaled reliability and superior service.
Medical jobs for medical experts. On-demand physician-only consulting marketplace. Source and secure physician talent within your budget.
Genesee Scientific, a life science products company, is a leading supplier of products to global life science research markets. With thousands of products available, its markets include pharmaceutical and biotechnology companies, medical research institutions, research and development laboratories, universities, colleges and secondary education institutions, hospitals, reference labs, and quality control/process control laboratories.
.png)
Lena Biosciences is a biotechnology company offering advanced, organ-on-a-chip and 3D cell culture products for precision therapy testing.
Over 10 years ago, Peachtree was founded to fill a perceived missing principle in typical CRO services. Where can I find a CRO that will partner with me, understand my challenges, and solve issues to keep my program on track? Filling this need requires experienced clinical research professionals. We focused on people – building an organization by investing in highly experienced personnel with broad therapeutic area expertise in a number of clinical trials. From single-center Phase I to global multi-center trials. Most all of our clinical personnel have both sponsor and CRO experience – allowing us to fully understand the issues our sponsor-clients face. We built a rock-solid processes and systems infrastructure to support the teams and this investment continues today – always seeking to improve our service. We also saw the opportunity to support an under-served segment of the market – emerging mid-sized companies. We felt they could benefit from access to highly-experienced teams that understand the challenges of limited resources and be flexible, reliable, and responsive. Most of all – provide solutions. So where is Peachtree today? A full-service CRO offering project management, feasibility & subject recruitment, clinical site management & monitoring, data management, biostatistics, medical monitoring, medical writing, and clinical quality assurance We are 80+ highly-experienced clinical research professionals with an average of more than 20 years relevant clinical experience Our client roster continues to grow having worked with nearly 100 pharmaceutical, biotech, and medical device companies providing full-service clinical trial support to niche services Continued investment in best-in-class systems such as IBM Clinical for EDC, Veeva Vault for eTMF, ZenQMS for quality management and training, and Oracle for CTMS
CinRx Pharma is a mosaic of biotechnology companies supported by a dedicated funding mechanism designed to improve drug development success by accelerating promising new medicines to patients. Integrating our pre-clinical, clinical and operational expertise with multiple shots on goal, we customize the optimal development trajectory for each pipeline candidate – a drug development superhighway. Our deliberate approach to asset selection is driven by deep operational and scientific expertise combined with decades of experience treating patients and developing new drugs. We invest in candidate drugs that have the potential for transformational change in the way a disease area is treated and significantly improves the patient experience and quality of life.
Anton Paar develops, produces, distributes and provides support for analytical instruments used in research, development and quality control worldwide. Ever since Mr. Anton Paar founded his one-man workshop in 1922, the Austrian based company has continuously found new ways to merge high-precision engineering with scientific curiosity. The company currently has more than 3500 employees and is active in over 170 countries worldwide. Anton Paar is the world market leader in the field of density measurement, the determination of dissolved CO2 and the analysis of materials’ deformation and flow behavior. Customers of Anton Paar include the largest international soft drink producers and breweries, petroleum and food companies, the chemical and pharmaceutical industries, Formula 1 racing teams and many more. Our innovation builds on research and development, but goes beyond technology and involves all of Anton Paar’s employees. Innovation is the art of finding answers before the question is asked. Customers deserve reliable application solutions which are precise, economic and easy to use. Anton Paar customers can always expect more.
Aktiv Pharma Group brings peace of mind to people at risk and their communities by developing simple-to-use emergency treatment technologies. Initially developed for the military, the ARAI™ is a prefilled auto-injector that uses single-hand, single-step activation. Now, ARAI is being developed to help people with life-threatening conditions in emergency situations, such as hypoglycemia, anaphylaxis and opioid overdose. Aktiv's platform technology has been used in a variety of form factors—including pre-filled syringes, auto-injectors, oral and topical dispensers, and IV transfer systems—which serve a broad range of medical applications. The flexible platform can be configured to carry a single drug solution or individually store multiple drug constituents that are either injected separately or automatically mixed just prior to injection. To learn more about career or investment opportunities, please visit www.aktivax.com.
At the heart of iA, we are passionate about pharmacy. Everything we do is designed to enable pharmacists to make a difference in the health and wellbeing of their patients. With over 25 years in the pharmacy fulfillment business, we have invented and developed a suite of leading-edge software enabled pharmacy fulfillment solutions. From our intelligent Pharmacy Operations Software Platform, to our modular and sophisticated counting and collation devices and our strategic partners, iA can run the prescription fulfillment process from end-to-end, helping pharmacies manage fulfillment and inventory to help lower costs, improve efficiency, and provide comprehensive Rx tracking and real-time support. For centralized fulfillment or pharmacy operations, let us focus on your prescription fulfillment so your pharmacists can focus on patient-facing care. iA is unleashing the full potential of pharmacy
Zogenix engages in the development and commercialization of products for the treatment of central nervous system disorders and pain.
Alfasigma USA is the local affiliate of the Italian based pharmaceutical company, Alfasigma. The company was formed in 2015 as a result of the merger between two historic Italian pharmaceutical companies, Alfa Wassermann and Sigma-Tau. Alfasigma is a leading Italian pharmaceutical company focused on prescription drugs, over-the counter (OTC) and nutraceutical products and has a presence in 90 countries. Alfasigma USA’s main goals are to improve the health and quality of life of patients by finding solutions to treat specific patient populations, expand our existing portfolio and bring new products into the US market. We strive to be a strong healthy company in a strong healthy world. Alfasigma USA is headquartered in Covington, LA., has a manufacturing plant in Shreveport, LA., a mail order pharmacy call center in the Covington location and an established national salesforce. In addition, a commercial operations hub opened in 2018. Alfasigma USA, Inc. distributes a portfolio of prescription products, both traditional and nutritional, to help individuals who are suffering from GI disorders, major depressive disorder, diabetic peripheral neuropathy and mild cognitive impairment. Through the company’s commitment to improving patients’ health and quality of life, Alfasigma USA, Inc. strives to provide innovative solutions that respond to the needs of a changing society. Discover Alfasigma USA at http://www.alfasigmausa.com.
We are a late-stage biopharmaceutical company focused on the development and commercialization of novel personalized therapeutics to treat cancer.
Janux Therapeutics is an innovative biopharmaceutical company developing next-generation therapeutics based on its proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to better treat patients suffering from cancer. Janux’s initial focus is on developing a novel class of T cell engagers (TCEs), and its lead product candidates are designed to target clinically validated drug targets. While TCE therapeutics have displayed potent anti-tumor activity in hematological cancers, developing TCEs to treat solid tumors have faced challenges due to the limitations of prior TCE technologies, namely (i) overactivation of the immune system leading to cytokine release syndrome, (ii) on-target, healthy tissue toxicities, and (iii) poor pharmacokinetics leading to short half-life. Janux is using its TRACTr platform technology to engineer product candidates designed to overcome these limitations. Janux is developing a broad pipeline with lead programs targeting prostate-specific membrane antigen (PSMA), epidermal growth factor receptor (EGFR), and trophoblast cell surface antigen 2 (TROP2), with all of its programs currently in the IND-enabling or discovery stage.
